Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV (2023) Tumor-induced osteomalacia: a comprehensive review. Endocr Rev 44(2):323–353. https://doi.org/10.1210/endrev/bnac026

Article  PubMed  Google Scholar 

Lee JC, Folpe AL (2020) Phosphaturic mesenchymal tumour. WHO Classification of Tumours Soft Tissue and Bone Tumours, 5th edn. IARC Press, Lyon, pp 284–286

Google Scholar 

Shah R, Lila AR, Jadhav RS, Patil V, Mahajan A, Sonawane S, Thadani P, Dcruz A, Pai P, Bal M, Kane S, Shah N, Bandgar T (2019) Tumor induced osteomalacia in head and neck region: single center experience and systematic review. Endocr Connect 8(10):1330–1353. https://doi.org/10.1530/EC-19-0341

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riminucci M, Colangelo L, Ungari C, Cassoni A, Minisola S, Corsi A (2022) Naso-ethmoidal phosphaturic mesenchymal tumor: a rare tumor site for an uncommon paraneoplastic syndrome. Ear Nose Throat J 101(5):289–291. https://doi.org/10.1177/0145561320940869

Article  PubMed  Google Scholar 

Palmisano B, Pace A, Colangelo L, Polimeni R, Sonato C, Messineo D, Minisola S, Magliulo G, Riminucci M, Corsi A (2023) “Non-phosphaturic” variant of phosphaturic mesenchymal tumor of the middle ear expressing multiple phosphatonins. Ear Nose Throat J 3:1455613221149635. https://doi.org/10.1177/01455613221149635

Article  Google Scholar 

Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108(1):128–142. https://doi.org/10.1007/s00223-020-00691-6

Article  CAS  PubMed  Google Scholar 

Bosman A, Palermo A, Vanderhulst J, De Beur SMJ, Fukumoto S, Minisola S, Xia W, Body JJ, Zillikens MC (2022) Tumor-induced osteomalacia: a systematic clinical review of 895 cases. Calcif Tissue Int 111(4):367–379. https://doi.org/10.1007/s00223-022-01005-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S (2023) Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med 293(3):309–328. https://doi.org/10.1111/joim.13593

Article  PubMed  Google Scholar 

Colangelo L, Cipriani C, Pepe J, Corsi A, Sonato C, Follacchio G, Cilli M, Gianni W, Ferrone F, Moreschini O, Fitzpatrick LA, Minisola S (2018) A challenging case of tumor-induced osteomalacia pathophysiological and clinical implications. Calcif Tissue Int 103(4):465–468. https://doi.org/10.1007/s00223-018-0429-x

Article  CAS  PubMed  Google Scholar 

Kritmetapak K, Kumar R (2023) Phosphatonins: from discovery to therapeutics. Endocr Pract 29(1):69–79. https://doi.org/10.1016/j.eprac.2022.09.007.19

Article  PubMed  Google Scholar 

Bansal S, Khazim K, Suri R, Martin D, Werner S, Fanti P (2016) Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23. Clin Nephrol 85(1):57–62. https://doi.org/10.5414/CN108596.20

Article  PubMed  Google Scholar 

Colangelo L, Pepe J, Nieddu L, Sonato C, Scillitani A, Diacinti D, Angelozzi M, Cipriani C, Minisola S (2020) Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia. Osteoporos Int 31(7):1383–1387. https://doi.org/10.1007/s00198-020-05369-1

Article  CAS  PubMed  Google Scholar 

Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R (2020) Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. Bone 134:115300. https://doi.org/10.1016/j.bone.2020.115300

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kritmetapak K, Losbanos L, Berent TE, Ashrafzadeh-Kian SL, Algeciras-Schimnich A, Hines JM, Singh RJ, Kumar R (2021) Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD. BMC Nephrol 22(1):114. https://doi.org/10.1186/s12882-021-02311-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC (2002) Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 17(6):1102–1110. https://doi.org/10.1359/jbmr.2002.17.6.1102

Article  PubMed  Google Scholar 

Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86(3):802–806. https://doi.org/10.1073/pnas.86.3.802

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Liu WH, Yang B, Milman KI (2024) Primer on fibroblast growth factor 7 (FGF 7). Differentiation 139:100801. https://doi.org/10.1016/j.diff.2024.100801

Article  CAS  PubMed  Google Scholar 

Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R (2005) Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90(2):1012–1020. https://doi.org/10.1210/jc.2004-0357

Article  CAS  PubMed  Google Scholar 

Schmidt FN, Delsmann J, Yazigi B, Beil FT, Amling M, Oheim R (2024) Approaching virtual osteoid volume estimation and in-depth tissue characterization in patients with tumor-induced osteomalacia. J Bone Miner Res 39(2):116–129. https://doi.org/10.1093/jbmr/zjae008

Article  PubMed  PubMed Central  Google Scholar 

Zanchetta MB, Corsi A (2024) Bone biopsy for the diagnosis of osteomalacia. Can we avoid it? J Bone Miner Res 39(5):515–516. https://doi.org/10.1093/jbmr/zjae046

Article  PubMed  Google Scholar